US Liver Biopsy Market: Will High-Tech Needles Win the War Against Non-Invasive Tests? The diagnostic landscape in 2026 is witnessing a high-stakes rivalry between traditional tissue sampling and emerging "liquid" alternatives. While non-invasive tests like elastography are gaining massive traction for routine screening, the US liver biopsy market is identifying as the essential "confirmatory" powerhouse for complex cases. With an estimated valuation approaching $1.1 billion this...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
thai
English
French
Spanish
Portuguese
Romaian
Portuguese (Brazil)
china